Squarepoint Ops LLC Fibrogen Inc Transaction History

Squarepoint Ops LLC

$99.2 Billion
Q4 2024

A detailed history of Squarepoint Ops LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 386,752 shares of FGEN stock, worth $216,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares

386,752

Holding current value

$216,581

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.3 - $0.58 $116,025 - $224,316	386,752 New	386,752 $204,000
Q2 2024 Aug 14, 2024	BUY	$0.89 - $2.36 $144,993 - $384,477	162,914 New	162,914 $144,000
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $258,429 - $2.14 Million	103,787 Added 244.98%	146,152 $394,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $675,721 - $1.07 Million	42,365 New	42,365 $790,000
Q3 2022 Nov 14, 2022	BUY	$11.4 - $14.6 $524,833 - $672,154	46,038 Added 207.08%	68,270 $888,000
Q2 2022 Aug 15, 2022	BUY	$7.94 - $12.96 $176,522 - $288,126	22,232 New	22,232 $235,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.79 $212,213 - $296,427	-17,655 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $561,710 - $870,566	-56,567 Reduced 76.21%	17,655 $249,000
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $555,430 - $1.45 Million	54,561 Added 277.51%	74,222 $759,000
Q2 2021 Aug 16, 2021	SELL	$18.57 - $35.68 $326,627 - $627,575	-17,589 Reduced 47.22%	19,661 $524,000
Q1 2021 May 17, 2021	BUY	$31.0 - $55.72 $738,513 - $1.33 Million	23,823 Added 177.43%	37,250 $1.29 Million
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $428,055 - $565,162	-11,541 Reduced 46.22%	13,427 $498,000
Q3 2020 Nov 16, 2020	BUY	$40.47 - $45.5 $728,338 - $818,863	17,997 Added 258.17%	24,968 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $227,045 - $298,567	6,971 New	6,971 $283,000
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $1.33 Million - $2.61 Million	-56,887 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $1.97 Million - $2.73 Million	56,887 New	56,887 $2.44 Million
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $2.21 Million - $3.1 Million	-51,663 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $1.96 Million - $3.11 Million	51,663 New	51,663 $2.39 Million
Q4 2017 Feb 14, 2018	SELL	$41.95 - $60.1 $295,831 - $423,825	-7,052 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $235,536 - $380,102	7,052	7,052 $379,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

37.4M

Call Options Held

351K

Put Options Held

105K

Armistice Capital, LLC New York, NY

6.8M
Shares

$3.81 Million
0.05% of portfolio
Vanguard Group Inc Valley Forge, PA

5.88M
Shares

$3.29 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

4.62M
Shares

$2.59 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.91M
Shares

$2.19 Million
0.01% of portfolio
Black Rock Inc. New York, NY

2.41M
Shares

$1.35 Million
0.0% of portfolio

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $52.5M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account